Chemical inhibitors of KCNG3 operate by various mechanisms to impede the protein's function as a voltage-gated potassium channel. Quinidine, for instance, can directly inhibit the conductance of potassium ions through KCNG3, which diminishes its functional role in contributing to the membrane potential. Similarly, Tetraethylammonium (TEA) acts as a blocker for potassium channels like KCNG3 by occluding the channel pore, which effectively prevents the flow of potassium ions. This action directly inhibits the electrical signaling that KCNG3 is responsible for in cells. Another inhibitor, 4-Aminopyridine, targets the channel pore of KCNG3, impeding the efflux of potassium ions crucial for electrical signaling. Additionally, Correolide can bind to KCNG3 and stabilize the channel in its closed state, resulting in reduced potassium ion conductance.
In the same vein, Clofilium Tosylate inhibits KCNG3 by lessening potassium ion conductance, which is integral to maintaining the resting potential and the repolarization phase of action potentials within cells. Dofetilide and E-4031 share a similar inhibitory mechanism on KCNG3 by blocking the channel's pore, thus preventing the standard flow of potassium ions, disrupting the electrical signaling. Linopirdine blocks KCNG3, thereby diminishing potassium ion efflux, which is vital for signal propagation. Sotalol acts by obstructing the pore of KCNG3, which reduces repolarization currents that are essential for electrical signaling within the heart and nervous system. AVE0118 blocks specific potassium channels, including KCNG3, and inhibits the protein by interfering with its ability to conduct potassium ions. Astemizole, while primarily an antihistamine, also blocks certain potassium channels, including KCNG3, by reducing the conductance of potassium ions through the channel. Lastly, XE991 is a potent blocker of KCNQ potassium channels and can inhibit KCNG3 by attenuating the flow of potassium ions, which is critical for the regulation of cellular excitability and signal transmission.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine is known to inhibit voltage-gated potassium channels, and KCNG3 is a member of this family. This chemical can inhibit the conductance of potassium ions through KCNG3, reducing its ability to contribute to the membrane potential. | ||||||
Tetraethylammonium chloride | 56-34-8 | sc-202834 | 25 g | $45.00 | 2 | |
Tetraethylammonium (TEA) has been shown to block various potassium channels. It can inhibit KCNG3 by occluding the potassium channel pore, thereby preventing potassium ion flow and inhibiting the channel's function. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $38.00 $1155.00 $122.00 | 3 | |
4-Aminopyridine is a known potassium channel blocker that can inhibit KCNG3 by blocking the pore of the channel, which impedes the efflux of potassium ions, crucial for the channel's electrical signaling. | ||||||
Clofilium tosylate | 92953-10-1 | sc-391228 sc-391228A | 25 mg 100 mg | $437.00 $1040.00 | 1 | |
Clofilium Tosylate is a blocker of potassium channels and can inhibit KCNG3 by reducing potassium ion conductance, essential for maintaining the resting potential and repolarization phase of the action potential. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $68.00 $251.00 | 3 | |
Sotalol inhibits various potassium channels, and it can inhibit KCNG3 by blocking the channel pore, which reduces the repolarization currents essential for electrical signaling within the heart and nervous system. | ||||||